Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Nature Medicine2003Vol. 9(5), pp. 568–574
Citations Over TimeTop 1% of 2003 papers
Toshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, Shirley V. Hodgson, Christopher G. Mathew, Hans Joenje, Samuel C. Mok, Alan D. D’Andrea
Related Papers
- → Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants(2002)78 cited
- → Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia(2003)62 cited
- → In silico study of missense variants of FANCA, FANCC and FANCG genes reveals high risk deleterious alleles predisposing to Fanconi anemia pathogenesis(2021)6 cited
- → Fanconi anemia protein complex is a novel target of the IKK signalsome(2002)27 cited
- The molecular biology of Fanconi anemia.(2002)